PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Long COVID most prevalent in the most seriously ill

2023-10-27
(Press-News.org) A collaborative study involving researchers from Karolinska Institutet has charted the prevalence of severe physical symptom burden amongst Scandinavians for up to two years after a SARS-CoV-2 infection. Most affected were people who had a severe COVID-19 infection, while the researchers found no elevated prevalence of long COVID in those who had never been bedridden. The study is published in The Lancet Regional Health – Europe.

By mid-October 2023, over 771 million cases of COVID-19 had been reported to the World Health Organization (WHO). An estimated 10 to 20 per cent of the affected have persistent symptoms.

Close to 65,000 participants

In the present study, researchers examined the prevalence of persistent physical symptoms in people with different degrees of COVID-19 severity and compared them with people who had not had a confirmed COVID-19 diagnosis. The study comprised 64,880 adults from Sweden, Denmark, Norway and Iceland with self-reported physical symptoms between April 2020 and August 2022.

Over 22,000 of the participants were diagnosed with COVID-19 during the period, almost 10 per cent of whom were bedridden for at least seven days. The prevalence of chronic symptoms such as shortness of breath, chest pain, dizziness, headaches, and low energy/ fatigue, was 37 per cent higher in those who had had a COVID-19 diagnosis than in those who had not.

Patients who had been bedridden for at least seven days during the SARS-CoV-2 infection had the highest prevalence of severe physical symptom burden, over double that of those not diagnosed with COVID-19. They also had the most persistent symptoms for up to two years after diagnosis.

The symptoms might need longer monitoring

“Long COVID has grown into a major public health problem since a large proportion of the global population has been infected,” says Emily Joyce, doctoral student at the Institute of Environmental Medicine, Karolinska Institutet in Sweden and one of the study’s first authors. “Our results show the long-term health consequences of the pandemic and highlight the importance of monitoring physical symptoms for up to two years after diagnosis, especially in people who experienced severe COVID-19.”

The majority of the participants were fully or partially vaccinated, and the results were largely the same in analyses of exclusively vaccinated individuals.

Participants who had never been bedridden during their infection presented with a similar prevalence to people who had not been diagnosed with COVID-19.

For this study, the researchers combined four cohorts from COVIDMENT, a large-scale collaborative project among Sweden, Denmark, Norway, Iceland, Estonia and Scotland.

Studying the long-term health impact

“We’ll continue to assess the long-term health impact of the COVID-19 pandemic in this project,” says corresponding author Qing Shen, affiliated researcher at the Institute of Environmental Medicine and the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet. “Multiple projects are underway, including studies of how COVID-19 has affected cognitive function and mental health, and how social isolation affected the elderly.”

The study was conducted in close collaboration with the universities of Oslo (Norway), Tartu (Estonia) and Edinburgh (Scotland), the University of Iceland and Copenhagen University Hospital, Rigshospitalet in Denmark. It was financed primarily by grants from NordForsk and the EU Horizon 2020 programme. The Swedish leg of the study received a grant from Forte (the Swedish Research Council for Health, Working Life and Welfare). There are no reported conflicts of interest.

Publication: ”COVID-19 illness severity and 2-year prevalence of physical symptoms: an observational study in Iceland, Sweden, Norway and Denmark”, Qing Shen et al, The Lancet Regional Health – Europe, online 27 October 2023, doi: 10.1016/j.lanepe.2023.100756.

END


ELSE PRESS RELEASES FROM THIS DATE:

Scientists build on artificial intelligence to create next-generation gastric acid treatment

Scientists build on artificial intelligence to create next-generation gastric acid treatment
2023-10-27
Researchers at Nagoya University in Japan created and improved artificial intelligence (AI) designs to synthesize a candidate compound for a new gastric acid inhibitor with a better binding affinity than existing drugs. Their findings, published in Communications Biology, suggest a new way to work in tandem with AI to develop pharmaceuticals.  Stomach acid is a crucial component of food digestion. However, when the balance of gastric mucosal secretion is disturbed, stomach acid can cause discomfort and, in severe cases, conditions such as gastric ulcers and reflux esophagitis. Therefore, many people turn to gastric acid suppressants, most of which target the gastric ...

Is it possible for random bit generator to reach a rate of Peta bits/s?

Is it possible for random bit generator to reach a rate of Peta bits/s?
2023-10-27
The optical frequency comb is an important tool in modern physics research and applications. In 2005, Theodor W. Hänsch and John L. Hall were awarded the Nobel Prize in Physics for their pioneering work on optical frequency comb technology. This sparked a great interest among researchers in the field, leading to a series of studies on optical frequency combs. Advanced nanophotonic technology has enabled integrated microresonators with ultrahigh Q factors and chip-scale microcombs. Among various comb dynamic states, a chaotic comb has high nonlinearity. In a chaotic comb, each comb tooth exhibits a chaotic dynamic ...

A new NIR-PIT biomarker paves the way for targeted cancer treatments

A new NIR-PIT biomarker paves the way for targeted cancer treatments
2023-10-27
Researchers at Nagoya University in Japan and their collaborators have used a biomarker based on microbubbles to evaluate the success of near-infrared photoimmunotherapy (NIR-PIT) treatment. Using ultrasound to track the microbubbles, they were able to identify areas where cancer therapy had not been fully applied. Their findings suggest ways to improve NIR-PIT and make it a viable alternative treatment for various types of cancer.     NIR-PIT is an innovative cancer treatment that combines the use of antibodies and near-infrared light to ...

Number of dementia cases could be 42% higher than previously estimated by 2040

2023-10-27
Up to 1.7 million people could be living with dementia in England and Wales by 2040 – over 40% more than previously forecast – finds a new UCL-led study. Previous studies, based on data up to 2010, showed that dementia incidence had declined in high-income countries. However, the new research, published in The Lancet Public Health, indicates that dementia incidence started to increase in England and Wales after 2008. Based on this estimated upward incidence trend, researchers project that the number of people with dementia in England and Wales may be significantly higher than expected in the future. According to previous research* in England ...

Youngest children in class with ADHD as likely to keep diagnosis in adulthood as older pupils, find scientists

Youngest children in class with ADHD as likely to keep diagnosis in adulthood as older pupils, find scientists
2023-10-27
Lancet Psychiatry study shows for first time that younger children are no more likely to lose ADHD diagnosis over time than older classmates Experts in charge of study examined data from more than 6,500 patients with ADHD 360 million people worldwide have been diagnosed with the condition according to WHO – with around a third under the age of 18   Children who are the youngest in their class to be identified with ADHD are just as likely to keep the diagnosis as older pupils in their year group, scientists have found. Experts from the University of Southampton ...

Effective treatment for rare sight-threatening infection

2023-10-27
A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial. The findings, published in Ophthalmology, describe the efficacy and safety of the first drug candidate for the treatment of Acanthamoeba keratitis (AK), applying a novel and evidence-based treatment protocol. AK is one type of microbial keratitis (corneal infection) – a condition ...

Controlling waves in magnets with superconductors for the first time

Controlling waves in magnets with superconductors for the first time
2023-10-27
Quantum physicists at Delft University of Technology have shown that it’s possible to control and manipulate spin waves on a chip using superconductors for the first time. These tiny waves in magnets may offer an alternative to electronics in the future, interesting for energy-efficient information technology or connecting pieces in a quantum computer, for example. The breakthrough, published in Science, primarily gives physicists new insight into the interaction between magnets and superconductors. Energy-efficient substitute "Spin waves are waves in a magnetic material that we can use to transmit information," explains ...

$1.5 million DOD grant will create virtual reality test to assess TBI in the field

2023-10-27
One of the most common injuries sustained by military personnel in recent conflicts has been traumatic brain injury, or TBI. In response to this, and the fact that military operations are increasingly being conducted by small teams in far-flung areas, researchers in the University of Arizona College of Medicine – Tucson’s Department of Psychiatry are working on a portable virtual reality system to assess TBI in the field. Psychiatry professor William “Scott” Killgore, PhD, and his team in the Social, ...

Antibody-drug conjugate helps patients with metastatic non-small cell lung cancer live longer, delaying disease progression

2023-10-27
Treatment with datopotamab deruxtecan (Dato-DXd), a novel Trop-2 directed antibody-drug conjugate, was found to significantly improve progression-free survival in patients with metastatic non-small cell lung cancer, an improvement that was primarily driven by patients with non-squamous tumors. These results from the TROPION-Lung01 Phase III trial, which compared the standard of care in second-line docetaxel, a type of chemotherapy, with Dato-DXd, an antibody drug conjugate, in patients with pretreated metastatic non-small cell lung cancer, were presented at the European Society for Medical Oncology 2023 Congress by Dr. Aaron ...

UTHSC cancer researcher part of $3 million collaborative project studying obesity-related cancer

2023-10-27
A University of Tennessee Health Science Center (UTHSC) researcher is a member of a prestigious team that has just received a highly competitive Endeavor Award totaling $3 million from The Mark Foundation for Cancer Research. Liza Makowski, PhD professor in Hematology and Oncology at the UTHSC Center for Cancer Research, is a co-principal investigator on the award, which funds collaborative projects tackling complex challenges in the prevention, diagnosis, and treatment of cancer. Entitled “Inflammatory Drivers of The Obesity-Cancer Connection”, the project is led by principal ...

LAST 30 PRESS RELEASES:

Breathable yet protective: Next-gen medical textiles with micro/nano networks

Frequency-engineered MXene supercapacitors enable efficient pulse charging in TENG–SC hybrid systems

Developed an AI-based classification system for facial pigmented lesions

Achieving 20% efficiency in halogen-free organic solar cells via isomeric additive-mediated sequential processing

New book Terraglossia reclaims language, Country and culture

The most effective diabetes drugs don't reach enough patients yet

Breast cancer risk in younger women may be influenced by hormone therapy

Strategies for staying smoke-free after rehab

Commentary questions the potential benefit of levothyroxine treatment of mild hypothyroidism during pregnancy

Study projects over 14 million preventable deaths by 2030 if USAID defunding continues

New study reveals 33% gap in transplant access for UK’s poorest children

Dysregulated epigenetic memory in early embryos offers new clues to the inheritance of polycystic ovary syndrome (PCOS)

IVF and IUI pregnancy rates remain stable across Europe, despite an increasing uptake of single embryo transfer

It takes a village: Chimpanzee babies do better when their moms have social connections

From lab to market: how renewable polymers could transform medicine

Striking increase in obesity observed among youth between 2011 and 2023

No evidence that medications trigger microscopic colitis in older adults

NYUAD researchers find link between brain growth and mental health disorders

Aging-related inflammation is not universal across human populations, new study finds

University of Oregon to create national children’s mental health center with $11 million federal grant

Rare achievement: UTA undergrad publishes research

Fact or fiction? The ADHD info dilemma

Genetic ancestry linked to risk of severe dengue

Genomes reveal the Norwegian lemming as one of the youngest mammal species

Early birds get the burn: Monash study finds early bedtimes associated with more physical activity

Groundbreaking analysis provides day-by-day insight into prehistoric plankton’s capacity for change

Southern Ocean saltier, hotter and losing ice fast as decades-long trend unexpectedly reverses

Human fishing reshaped Caribbean reef food webs, 7000-year old exposed fossilized reefs reveal

Killer whales, kind gestures: Orcas offer food to humans in the wild

Hurricane ecology research reveals critical vulnerabilities of coastal ecosystems

[Press-News.org] Long COVID most prevalent in the most seriously ill